Back

Bridging The Gaps In EMPEROR-Preserved: Toward safer and smarter use of Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction

European Heart Journal

4 November 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY HEART FAILURE Chronic Heart Failure HYPERTENSION

Contributors

Maham Fatima
Maham Fatima

Author

Sajal Sheikh
Sajal Sheikh

Author

Zara Ammer
Zara Ammer

Author

You may be interested in
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Presentation
Presence of heart failure in pts with coronary artery disease and artery hypertension
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives

ESC 365 is supported by

novartis Explore sponsored resources